RadiotherapyRadiation DosageRadiation InjuriesRadiotherapy DosageRadiation, IonizingDose-Response Relationship, RadiationRadiation ToleranceRadiotherapy, ConformalRadiotherapy, AdjuvantRadiationAntineoplastic AgentsRadiation ProtectionCombined Modality TherapyRadiation OncologyRadiotherapy, Intensity-ModulatedRadiation MonitoringRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyDose FractionationRadiation PneumonitisNeoplasmsRadiotherapy, Computer-AssistedCell Line, TumorNeoplasms, Radiation-InducedRadiotherapy, Image-GuidedRadiation-Sensitizing AgentsRadiation Injuries, ExperimentalRadiometryGamma RaysDrug Screening Assays, AntitumorCosmic RadiationCisplatinBrachytherapyTreatment OutcomeDoxorubicinHead and Neck NeoplasmsRadiosurgeryRadiation-Protective AgentsBackground RadiationApoptosisBrain NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCell SurvivalNeoplasm Recurrence, LocalChemoradiotherapyUltraviolet RaysNeoplasm StagingCarcinoma, Squamous CellBreast NeoplasmsDNA DamageCobalt RadioisotopesRadiation EffectsRadiodermatitisParticle AcceleratorsDrug Resistance, NeoplasmAntineoplastic Agents, PhytogenicTime FactorsRetrospective StudiesDisease-Free SurvivalOrgans at RiskRadiobiologyCranial IrradiationFluorouracilMice, NudeSurvival RateSurvival AnalysisNasopharyngeal NeoplasmsTumor Cells, CulturedXenograft Model Antitumor AssaysAntibiotics, AntineoplasticLung NeoplasmsEtoposideFollow-Up StudiesTomography, X-Ray ComputedX-RaysDrug Delivery SystemsAcute Radiation SyndromeChemotherapy, AdjuvantPrognosisAdenocarcinomaRectal NeoplasmsVincristineCell ProliferationPaclitaxelDacarbazineDNA RepairRadioactive Hazard ReleaseDrug CarriersAntineoplastic Agents, AlkylatingLinear Energy TransferGlioblastomaPelvic NeoplasmsBleomycinRadiation Hybrid MappingDose-Response Relationship, DrugTumor BurdenMastectomy, SegmentalProstatic NeoplasmsRelative Biological EffectivenessGlioma